Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
15.23
-0.33
(-2.12%)
At close: February 24 at 4:00:00 PM EST
15.23
0.00
(0.00%)
After hours: February 24 at 4:32:11 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
696,382
758,035
609,366
332,975
Total Liabilities Net Minority Interest
135,017
135,993
143,324
148,969
Total Equity Gross Minority Interest
561,365
622,042
466,042
184,006
Total Capitalization
561,365
622,042
466,042
184,006
Common Stock Equity
561,365
622,042
466,042
184,006
Capital Lease Obligations
11,835
6,473
12,326
17,838
Net Tangible Assets
561,365
622,042
466,042
184,006
Working Capital
582,391
668,951
551,357
273,436
Invested Capital
561,365
622,042
466,042
184,006
Tangible Book Value
561,365
622,042
466,042
184,006
Total Debt
11,835
6,473
12,326
17,838
Share Issued
53,682.12
52,103.61
46,660.29
39,921.41
Ordinary Shares Number
53,682.12
52,103.61
46,660.29
39,921.41
12/31/2020 - 12/18/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PTCT PTC Therapeutics, Inc.
50.02
-1.32%
RCUS Arcus Biosciences, Inc.
10.16
-8.22%
SRRK Scholar Rock Holding Corporation
37.16
-1.43%
STOK Stoke Therapeutics, Inc.
8.50
+2.04%
AGIO Agios Pharmaceuticals, Inc.
35.47
+0.71%
BBIO BridgeBio Pharma, Inc.
36.25
-1.63%
PRAX Praxis Precision Medicines, Inc.
66.71
-10.44%
RARE Ultragenyx Pharmaceutical Inc.
41.84
-1.76%
PTGX Protagonist Therapeutics, Inc.
36.00
-7.10%
IMVT Immunovant, Inc.
20.43
-3.95%